To the US, Drug company Pfizer has submitted an emergency request for the authorisation of its Covid-19 vaccine for use in children aged from five to 11.
The Food and Drug Administration has promised to move quickly on the request.
New York correspondent Will Denselow spoke to Corin Dann.
